Given the heterogeneity found in neurodevelopmental disorders like FXS, stringent methodological standards were used to obtain reliable delineation and quantification of mGluR5 occupancy differences between healthy and disorder groups, critical for biomarker research. Here, GRM5 is linked to fragile X syndrome.